Clinical Trial Update: A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a Phase 1/Phase 2 study at Ain Shams University comparing dexmedetomidine and methylprednisolone to modulate inflammatory response i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Ain Shams University | Conditions: Coronary Artery Disease, Systemic Inflammatory Response Syndrome | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING